The first edition of novel coronavirus vaccination guidelines released! Quick view →

On the 29th, the National Health Commission issued the “technical guidelines for new coronavirus vaccination (First Edition)”, which makes clear provisions on when people with previous infections can get the new coronavirus vaccine, whether people under the age of 18 and pregnant women can get the new coronavirus vaccine, etc

.

The first edition of the vaccination guidelines clearly indicates that these five categories of people are not suitable for vaccination

.

The first edition of the new coronavirus vaccination technical guidelines issued by the National Health Commission on March 29, the latest clearly states that five categories of people are not suitable for vaccination: those who are allergic to the active ingredients of the vaccine, any non active ingredients, substances used in the production process, or those who have been allergic to the same kind of vaccine before; those who have had severe adverse reactions to the vaccine in the past Allergic reaction (such as acute allergic reaction, angioneurotic edema, dyspnea, etc.); patients with uncontrolled epilepsy and other serious nervous system diseases (such as transverse myelitis, Guillain Barre syndrome, demyelinating disease, etc.); patients with fever, acute attack of acute disease or chronic disease, or uncontrolled severe chronic disease; pregnant women

.

What should be paid attention to in these six specific groups? People aged 60 and above are at high risk of severe illness and death

.

At present, the number of phase III clinical trials of four new coronavirus vaccines approved for marketing is limited, and there is no data on the protective effect of the vaccine on this population

.

However, the data of phase I / II clinical study showed that the safety of vaccination in this population was good

.

Compared with the population aged 18-59, the titer of neutralizing antibody after vaccination was slightly lower, but the positive conversion rate of neutralizing antibody was similar, suggesting that the vaccine would also have a certain protective effect on the population aged over 60, so vaccination is recommended

.

At present, the existing vaccines for people under the age of 18 have not obtained the clinical trial data for this population, so it is not recommended to vaccinate people under the age of 18

.

Chronic patients group chronic patients group is a severe and high risk group of death after infection with new coronavirus

.

The chronic patients with stable health and good drug control are not taboo population for new coronavirus vaccination, so vaccination is recommended

.

Based on the understanding of the safety of the above vaccines, it is not recommended to take special medical measures (such as termination of pregnancy) just because of the new coronavirus vaccine, and it is recommended to do a good job in pregnancy examination and follow-up

.

For women who have a pregnancy plan, it is not necessary to delay the pregnancy plan just because of the new coronavirus vaccine

.

Although there is no clinical research data on the impact of new coronavirus vaccination on lactating infants among lactating women, based on the understanding of the safety of the vaccine, it is recommended to vaccinate lactating women (such as medical staff) with high risk of new coronavirus infection

.

Considering the importance of breast-feeding to infant nutrition and health, referring to the international practice, it is suggested that breast-feeding should be continued after breast-feeding women are vaccinated with new coronavirus vaccine

.

People with impaired immune function are at high risk of death after infection with new coronavirus

.

At present, there is no data on the safety and effectiveness of the new coronavirus vaccine for this population (such as cancer, nephrotic syndrome, AIDS patients) and human immunodeficiency virus (HIV) infected people

.

The immune response and protective effect of these people may be reduced after vaccination

.

For inactivated vaccine and recombinant subunit vaccine, vaccination is recommended according to the safety characteristics of the same type of vaccine in the past; for adenovirus vector vaccine, although the vector virus used is replication defective, there is no safety data of the same type of vaccine in the past, vaccination is recommended after full notice that individual benefits outweigh risks

.

Previous studies on patients or infected persons with new coronavirus show that re infection is rare within 6 months after new coronavirus infection

.

Novel coronavirus pneumonia patients (patients or asymptomatic infections) were given 1 doses of antibiotics after 6 months

.

Click in the lower left corner“

.